期刊
CLINICAL INFECTIOUS DISEASES
卷 52, 期 1, 页码 99-114出版社
OXFORD UNIV PRESS INC
DOI: 10.1093/cid/ciq067
关键词
-
资金
- National Health and Medical Research Council, Australia
- Austin Hospital Medical Research Foundation
- Royal Australasian College of Physicians
There is significant diversity in methicillin-resistant Staphylococcus aureus (MRSA) clones arising in the community worldwide, with considerable geographical differences in typical antimicrobial resistance profiles. Many community clones of MRSA have a non-multidrug resistant antimicrobial profile, providing increased options for empirical and directed therapy of infections caused by these strains. However, the recent description of increasing non-beta lactam resistance in community clones of MRSA, especially USA300, provides a timely warning for clinicians making decisions about therapy for patients potentially infected with these strains. Continued monitoring of global epidemiology and emerging drug resistance data is critical for the effective management of these infections.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据